4/A: Perspective Therapeutics Director Amends Ownership Filing After Reverse Stock Split

A director of Perspective Therapeutics, Inc. has amended a previous filing to correct reported beneficial ownership figures following a 1-for-10 reverse stock split.

Summary

• A Form 4/A filing was submitted by Robert F. Williamson III, a director at Perspective Therapeutics, Inc., to correct previously reported beneficial ownership of common stock.
• The original Form 4, filed on November 27, 2024, contained incorrect figures due to a failure to account for a 1-for-10 reverse stock split that occurred in June 2024.
• The corrected filing shows direct ownership of 48,645 shares and indirect ownership of 366 shares through the RFW3 Revocable Trust.
• The original filing incorrectly reported 430,058 shares as directly owned and 3,663 shares as indirectly owned.

Sentiment

Score: 4

Explanation: The document highlights a reporting error, which is a negative, but it is a routine correction. The sentiment is therefore slightly negative.

Negatives

• The original Form 4 filing contained incorrect information regarding beneficial ownership.
• The error was due to a failure to account for a reverse stock split.

Risks

• Inaccurate reporting of beneficial ownership can lead to confusion and potential regulatory scrutiny.
• Failure to properly account for corporate actions like reverse stock splits can result in reporting errors.

Industry Context

This type of filing is a routine requirement for company insiders and directors to disclose changes in their ownership of company stock. The need for an amendment highlights the importance of accurate reporting, especially after corporate actions like reverse stock splits.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and are required by the SEC.
• The need for an amended filing is not uncommon, especially after corporate actions that affect share counts.
• Companies like Amgen (AMGN) and Gilead Sciences (GILD) also have directors who file similar forms when their ownership changes.

Stakeholder Impact

• Shareholders may have been temporarily misinformed about the director's ownership stake due to the initial error.
• The correction ensures transparency and accurate information for all stakeholders.

Key Dates

Keywords

beneficial ownership, Form 4, reverse stock split, Perspective Therapeutics, director, amendment, stock ownership, CATX